866-997-4948(US-Canada Toll Free)

Spinal Muscular Atrophy (SMA) - Epidemiology Insights to 2025

Published By :

DelveInsight

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 40 Pages

DelveInsights Spinal Muscular Atrophy (SMA) -Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Spinal Muscular Atrophy (SMA) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Spinal Muscular Atrophy (SMA). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Spinal Muscular Atrophy (SMA). The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

The Report includes the prevalent population and how will it change over the next eight years.
Coverage of key Spinal Muscular Atrophy (SMA) sub-populations and its prevalent or incident cases
Prevalent or incident cases segmented by age and sex.
The key differences in epidemiology patterns across the seven market segments.

Reasons to buy
Developing business strategies by understanding the trends shaping and driving the global Spinal Muscular Atrophy (SMA) market.
Identifying prevalent patient populations as well as risk factors in the global Spinal Muscular Atrophy (SMA) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Spinal Muscular Atrophy (SMA) therapeutics in each of the markets covered.

1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Spinal Muscular Atrophy (SMA) Overview
Spinal Muscular Atrophy (SMA) Definition
Pathophysiology
Symptoms
Etiology
5. Risk Factors Associated with Spinal Muscular Atrophy (SMA)
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Spinal Muscular Atrophy (SMA)
Sex-Specific Prevalent/Incident Cases of Spinal Muscular Atrophy (SMA)
Disease Type Specific Prevalent/Incident Cases of Spinal Muscular Atrophy (SMA)
8.Prevalent & Incident Cases by 7 MM-2015-2025
Spinal Muscular Atrophy (SMA) Epidemiology of United States-2025
Spinal Muscular Atrophy (SMA) Epidemiology of United Kingdom-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Germany-2025
Spinal Muscular Atrophy (SMA) Epidemiology of France-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Spain-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Italy-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Japan-2025
9. Key Takeaways
10. Appendix
11.Report Methodology
12. Consulting Services
13. Disclaimer
14. About Us

List of Table

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Spinal Muscular Atrophy (SMA) Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Japan (2015-2025)

List of Chart

July, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *